Cornerstone Therapeutics, Inc. · Cary, NC United States ·(NASDAQ (CM): CRTX)
Company Description
Phone: 919-678-6611
Fax: 866-443-3092
View Cornerstone Therapeutics, Inc. Locations On A US Map
This link will open in a new window
Cornerstone Therapeutics (formerly Critical Therapeutics) wants to help clear things up for the allergic, the asthmatic, the congested, and the inflamed. The drug company is focused on developing and commercializing therapeutic products to prevent and treat acute inflammation and other respiratory ailments. Its marketed products include AlleRx, Balacet, Deconsal, Spectracef, and Zyflo CR. Cornerstone Therapeutics was formed by the 2008 merger of Critical Therapeutics and privately held respiratory therapy firm Cornerstone BioPharma. Italian drugmaker Chiesi Farmaceutici owns a majority stake in the company. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Cornerstone Therapeutics, Inc. Financials
| Company Type | Public - NASDAQ (CM): CRTX Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $64.9 |
| 2008 Employees | 107 |
Cornerstone Therapeutics, Inc. Executives
13 executives listed for Cornerstone Therapeutics, Inc.'s Cary, NC location.
| Title | Name & Bio | Contact |
| Chairman, President, and CEO | Craig Collard | Network |
| EVP Finance, CFO, and Treasurer | David Price | Network |
| Chief Medical Officer | Brian Dickson | Network |
Competition
Competitive Landscape for Cornerstone Therapeutics, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Cornerstone Therapeutics, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
